Jinying Sun has not added Biography.
If you are Jinying Sun and would like to personalize this page please email our Author Liaison for assistance.
Transferrin epitope-CD19-CAR-T cells effectively kill lymphoma cells and .
Frontiers in bioscience (Landmark edition) Jan, 2020 | Pubmed ID: 31585889
Novel CD37, Humanized CD37 and Bi-Specific Humanized CD37-CD19 CAR-T Cells Specifically Target Lymphoma.
Cancers Feb, 2021 | Pubmed ID: 33652767
Novel CS1 CAR-T Cells and Bispecific CS1-BCMA CAR-T Cells Effectively Target Multiple Myeloma.
Biomedicines Oct, 2021 | Pubmed ID: 34680541
Bispecific BCMA-CD3 Antibodies Block Multiple Myeloma Tumor Growth.
Cancers May, 2022 | Pubmed ID: 35626122
mRNA-Lipid Nanoparticle (LNP) Delivery of Humanized EpCAM-CD3 Bispecific Antibody Significantly Blocks Colorectal Cancer Tumor Growth.
Cancers May, 2023 | Pubmed ID: 37345198
CAR-NK Cells Generated with mRNA-LNPs Kill Tumor Target Cells In Vitro and In Vivo.
International journal of molecular sciences Aug, 2023 | Pubmed ID: 37686170
HER2-CD3-Fc Bispecific Antibody-Encoding mRNA Delivered by Lipid Nanoparticles Suppresses HER2-Positive Tumor Growth.
Vaccines Jul, 2024 | Pubmed ID: 39066446
ProMab Biotechnologies
Liang Hu1,
Robert Berahovich1,
Yanwei Huang1,
Shiming Zhang1,
Jinying Sun1,
Xianghong Liu1,
Hua Zhou1,
Shirley Xu1,
Haoqi Li1,
Vita Golubovskaya1,
Lijun Wu1
1, ProMab Biotechnologies
Конфиденциальность
Условия эксплуатации
Политика
СВЯЖИТЕСЬ С НАМИ
РЕКОМЕНДОВАТЬ БИБЛИОТЕКЕ
НОВОСТИ JoVE
Исследования
JoVE Journal
Подборки методов
JoVE Encyclopedia of Experiments
Архив
Образование
JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Business
JoVE Quiz
JoVE Playlist
АВТОРЫ
Библиотекарь
Доступ
О JoVE
JoVE Sitemap
Авторские права © 2025 MyJoVE Corporation. Все права защищены